Answers are grounded in this paper and cite their sources.
Literature review reveals prenatal NSAID therapy may constrict the ductus arteriosus to resolve circular shunts in fetal Ebstein's anomaly, suggesting potential to improve fetal outcomes.
A circular shunt is a poor prognostic factor associated with Ebstein's anomaly. Targeting the constriction of the ductus arteriosus (DA) in order to limit or resolve the circular shunt, has been shown to improve fetal outcomes. Prenatal non-steroidal anti-inflammatory drugs (NSAIDs) have been known to constrict the DA. Recently, prenatal NSAIDs have been used for that purpose in the treatment of circular shunt. Limited research shows that it may be an effective treatment leading to improved fetal outcomes. In this article, we did an extensive review of literature to describe this therapy’s effectiveness and outcomes.
No takes yet. Share an insight, caveat, or question.
Peña et al. (2023) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: